Skip to main content
Premium Trial:

Request an Annual Quote

MDxHealth Signs on PPO Stratose

NEW YORK (GenomeWeb News) – MDxHealth today announced an agreement with preferred provider organization Stratose that gives its 12.4 million members access to the ConfirmMDx prostate cancer test.

Formerly operating as Coalition America, NPPN, OPPN, PlanCare America, 4MOST Health, Qualident and KeyClaims, Stratose has 850,000 direct and affiliate medical, dental, and workers' compensation provider contracts, MDxHealth said.

Jan Groen, CEO of MDxHealth, said that Stratose's network supplements more than 90 different third-party insurance payers. "With the addition of Stratose to our existing payer agreements, more than 80 million covered lives now have access to ConfirmMDx for prostate cancer," he said in a statement.

Today's announcement is the third deal MDxHealth has inked with a payor. In late July it said it signed agreements with healthcare cost management firm MultiPlan and PPO Three Rivers Provider Network to provide access to ConfirmMDx.

In late August, the Belgian firm said that revenues through the first half of 2013 had doubled year over year.

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.